1. Home
  2. LEGN vs OMF Comparison

LEGN vs OMF Comparison

Compare LEGN & OMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • OMF
  • Stock Information
  • Founded
  • LEGN 2014
  • OMF 1920
  • Country
  • LEGN United States
  • OMF United States
  • Employees
  • LEGN N/A
  • OMF N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • OMF Finance: Consumer Services
  • Sector
  • LEGN Health Care
  • OMF Finance
  • Exchange
  • LEGN Nasdaq
  • OMF Nasdaq
  • Market Cap
  • LEGN 7.0B
  • OMF 6.8B
  • IPO Year
  • LEGN 2020
  • OMF 2013
  • Fundamental
  • Price
  • LEGN $39.70
  • OMF $54.17
  • Analyst Decision
  • LEGN Strong Buy
  • OMF Buy
  • Analyst Count
  • LEGN 12
  • OMF 12
  • Target Price
  • LEGN $79.50
  • OMF $58.36
  • AVG Volume (30 Days)
  • LEGN 976.3K
  • OMF 1.1M
  • Earning Date
  • LEGN 03-10-2025
  • OMF 01-31-2025
  • Dividend Yield
  • LEGN N/A
  • OMF 7.68%
  • EPS Growth
  • LEGN N/A
  • OMF N/A
  • EPS
  • LEGN N/A
  • OMF 4.24
  • Revenue
  • LEGN $520,183,000.00
  • OMF $2,497,000,000.00
  • Revenue This Year
  • LEGN $121.13
  • OMF N/A
  • Revenue Next Year
  • LEGN $65.25
  • OMF $6.50
  • P/E Ratio
  • LEGN N/A
  • OMF $12.78
  • Revenue Growth
  • LEGN 122.96
  • OMF N/A
  • 52 Week Low
  • LEGN $30.17
  • OMF $41.70
  • 52 Week High
  • LEGN $70.13
  • OMF $58.90
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 64.82
  • OMF 43.39
  • Support Level
  • LEGN $34.36
  • OMF $54.14
  • Resistance Level
  • LEGN $36.39
  • OMF $57.79
  • Average True Range (ATR)
  • LEGN 1.67
  • OMF 1.48
  • MACD
  • LEGN 0.34
  • OMF -0.21
  • Stochastic Oscillator
  • LEGN 94.68
  • OMF 19.27

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About OMF OneMain Holdings Inc.

OneMain Holdings Inc is engaged in nonprime consumer finance companies in the United States and is one of only a few companies in the consumer installment lending industry. It formed after a transaction brought together two branch-based consumer finance companies with complementary strategies and locations. Its services include providing personal loan products, offering credit and noncredit insurance, servicing loans, pursuing strategic acquisitions and dispositions of assets and businesses, and on occasion, establishing joint ventures or forming strategic alliances. The company's one reportable segment is consumer and insurance. In addition to hundreds of branches, the company also has an online business. The main source of revenue is net interest income.

Share on Social Networks: